|
|
CT327 in the treatment of atopic dermatitis
| Third-party funded project |
| Project title |
CT327 in the treatment of atopic dermatitis |
| Principal Investigator(s) |
Itin, Peter
|
| Organisation / Research unit |
Bereich Spezialfächer (Klinik) / Dermatologie und Venerologie (Itin) |
| Project start |
01.01.2010 |
| Probable end |
31.12.2010 |
| Status |
Completed |
| Abstract |
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study of the Safety and Efficacy of CT 327, Pegylated K-252, formulated as a cream, when Administered Twice Daily for 14 days to Subjects with Mild-to-Moderate Atopic Dermatitis |
| Financed by |
Private Sector / Industry
|
| |
|
|
MCSS v5.8 PRO. 0.412 sec, queries - 0.000 sec
©Universität Basel | Impressum
|  |
|
14/05/2024
Research Database / FORSCHUNGSDATENBANK
|
